Journals / Klinik Psikofarmakoloji Bülteni / 2013 / Cilt: 23 - Sayı: 3

Anoreksiya nervoza ve esrar kötüye kullanı- mı: Olgu sunumu

Anorexia nervosa and cannabis abuse: A case report

Pages
272–275
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that, although cannabis caused increased appetite, she induced weight loss by self-induction of vomiting and excessive exercise.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is known that there is a high rate of comorbidity of alcohol-substance abuse and eating disorders.
📊
Key Findings & Data:The compounds of cannabis, such as tetrahydrocannabinol, activate endogenous cannabinoid receptors (CB1 and CB2) in the brain.
💡
Conclusion & Impact:It was found that, although cannabis caused increased appetite, she induced weight loss by self-induction of vomiting and excessive exercise.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It is known that there is a high rate of comorbidity of alcohol-substance abuse and eating disorders. The compounds of cannabis, such as tetrahydrocannabinol, activate endogenous cannabinoid receptors (CB1 and CB2) in the brain. Stimulating the CB1 receptor is known to cause increased appetite and an antiemetic effect and because of these effects cannabinoids are used clinically. In this case report, a young girl diagnosed anorexia nervosa and using cannabis will be presented. The patient, a 17 year-old, had complaints of loss weight and had used cannabis for three years. It was found that, although cannabis caused increased appetite, she induced weight loss by self-induction of vomiting and excessive exercise. According to a scan of the literature in Turkey, such a case of using cannabis comorbid with anorexia nervosa has not previously been reported. In this respect, discussion of the case in detail is important.

Özet

Alkol-madde bağımlılığı ile yeme bozukluğunun yüksekoranda komorbidite gösterdiği bilinmektedir. Esrarın tetrahidrokanabinol gibi aktif bileşenleri beyindekiendojen kanabinoid reseptörlerini (CB1 ve CB2 res.)etkinleştirir. CB1 reseptör stimülasyonunun iştah artışına yol açtığı ve antiemetik etki oluşturduğu bilinmekte olup, kanabinoidler bu etkileri nedeniyle tıbbi amaçlıkullanımda yer almaktadır. Bu vaka sunumunda esrar kullanan genç kadın hastada gelişen anoreksiya ner- voza tablosu aktarılacaktır. 17 yaşındaki hastanın kilo kaybı şikayeti ve 3 yıldır esrar kullanma öyküsü vardı. Esrarın iştah artırıcı etkisine rağmen hastada anoreksiyanervoza gelişmiştir; vakanın kendini kusturma ve aşırı egzersiz davranışlarıyla kilo kaybını sağladığı tespitedildi. Literatür taramamızda ülkemizde daha önceanoreksiya nervoza ve esrar kötüye kullanım komor- biditesi olan vaka saptanmamıştır; bu açıdan vakanınayrıntılı tartışılması önem arzetmektedir.

🔖

Cite This Article

EROL, A., KARAYILAN, S. (2022). Anoreksiya nervoza ve esrar kötüye kullanı- mı: Olgu sunumu. Klinik Psikofarmakoloji Bülteni, Cilt: 23 - Sayı: 3, 272–275. https://ajindex.com/articles/574045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Jacobi C, Morns L, Zwaan M. Risk factors, etiology and comorbidity: In Brewerton TD (editor). Clinical Handbook of Eating Disorders. South Carolina, USA: Marcel Dekker, 2004, 117-231
  2. Hantas Y, Maner F, Erkiran M, Turan F, Gokalp P. Characteristics of eating behavior and eating disorders in women with alcohol and substance abuse disorders. Düşünen Adam 2003;16(1):24-7. (Turkish
  3. Herzog DB, Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP. Drug abuse in women with eating disorders. Int J Eating Disord 2006;39(5):364-8
  4. Holderness CC, Brooks-Gunn J, Warren MP. Co-morbidity of eating disorders and substance abuse review of the literature. Int J Eat Disord 1994;16(1):1-34
  5. Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP, Herzog DB. Interactions Between Eating Disorders and Drug Abuse. J Nerv Ment Dis 2008;196(7);556-61
  6. Weiderman MW, Pryor T. Substance use among women with eating disorders. Int J Eat Disord 1996;20(2):163-8
  7. Alphan ET, Yilmaz N. Effects of endocannabinoid system on energy metabolism and obesity. Marmara Medical Journal 2007;20(3);202-14. (Turkish
  8. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004;3(9):771-84
  9. Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LMQ, Da Silveira DX. Therapeutic Use of Cannabis Sativa on Chemotherapy-Induced Nausea and Vomiting Among Cancer Patients: Systematic Review and Meta- Analysis. Eur J Cancer Care 2008;17(5):431-43
  10. Ross HE, Ivis F. Binge eating and substance use among male and female adolescents. Int J Eat Disord 1999;26(3):245-60
  11. Pisetsky EM, Chao YM, Dierker LC, May AM, Striegel-Moore RH. Disordered eating and substance use in high-school students: results from the Youth Risk Behavior Surveillance System. Int J Eat Disord 2008;41(5):464-70
  12. Maner F, Erkiran M, Hantas Y. Alcohol and non-alcohol substance abuse eating disorders in women: a controlled study. Bağımlılık Dergisi 2004;5(1):12-5. (Turkish)